CLINICAL_TRIALS
trial_result
· 2021-05-07
Clinical Trial Update: Effect of Mannitol 20% Versus Hypertonic Saline 7.5% in Brain Metabolism and Oxygenation [Phase 4]
Summary
A Phase 4 trial comparing Mannitol 20% to Hypertonic Saline 7.5% in brain metabolism and oxygenation for brain edema/metabolic disturbances has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aristotle University Of Thessaloniki | Conditions: Brain Edema, Metabolic Disturbance | Phase 4 | Status: COMPLETED